<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="186591">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00664690</url>
  </required_header>
  <id_info>
    <org_study_id>R-04-309</org_study_id>
    <secondary_id>10457</secondary_id>
    <nct_id>NCT00664690</nct_id>
  </id_info>
  <brief_title>Effect of Celecoxib on Transitional Pain After Outpatient Surgery</brief_title>
  <official_title>Effect of Celecoxib on Transitional Pain After Outpatient Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lawson Health Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Lawson Health Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sixty adults having shoulder and forearm surgery will receive either placebo or celebrex
      started preoperatively and continued for 3 days. Rescue medications required as well as pain
      scores will be assessed using a patient diary to evaluate the effect of celebrex in
      controlling transitional pain
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2004</start_date>
  <primary_completion_date type="Anticipated">December 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>visual analogue score for pain</measure>
    <time_frame>post-op period</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>severity of nausea</measure>
    <time_frame>post-op period</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>celebrex</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>celebrex</intervention_name>
    <description>400 mg celebrex given 1 hour preop and celebrex 200 mg BID postop</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>placebo given preop and BID postop</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients scheduled for elective ambulatory surgery of the shoulder

          -  ASA I - III

          -  Able to read English

          -  Male or female

        Exclusion Criteria:

          -  Allergy to local anesthetic, Cox2, sulpha drug, acetaminophen or oxycodone

          -  Women who are pregnant or lactating and women of childbearing age and not following
             acceptable contraceptive precautions

          -  Any major medical or psychiatric problem

          -  Those with a known history of narcotic dependence, abuse or chronic narcotic intake

          -  Patients with known history of peptic ulcer or GI bleeding in the past, ulcers,
             congestive heart failure, angina or previous heart attack, coagulation problems,
             venous thrombosis, kidney or liver disease or strokes
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ngozi Imasogie, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lawson Health Research Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ngozi Imasogie, MD</last_name>
    <phone>519-646-6000</phone>
    <phone_ext>64219</phone_ext>
    <email>nimasog@uwo.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>St. Joseph's Health Care</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Ngozi Imasogie, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>April 2008</verification_date>
  <lastchanged_date>April 22, 2008</lastchanged_date>
  <firstreceived_date>April 18, 2008</firstreceived_date>
  <responsible_party>
    <name_title>Dr. Ngozi Imasogie</name_title>
    <organization>Lawson Health Research Institute</organization>
  </responsible_party>
  <keyword>shoulder surgery</keyword>
  <keyword>analgesia</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Celecoxib</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
